Antiphospholipid syndrome: thrombosis, pregnancy morbidity and anticoagulation

Clinical scope and why this matters

Diagnosis requires a compatible thrombotic or pregnancy phenotype plus persistent antiphospholipid antibodies on appropriately spaced testing. Anticoagulation and pregnancy strategy depend on clinical phenotype and specialist guidance. Rheumatology requires distinction between inflammatory disease, infection, mechanical pain and mimics. Serology should answer a clinical question rather than substitute for examination; disease activity, accumulated damage, infection, bone and cardiovascular risk all matter.

Recognition and immediate priorities

Clarify the indication, current benefit, adherence, duplicate therapy, over-the-counter products, supplements and recent changes. The first-pass assessment should separate patients who can proceed through a routine pathway from those who need urgent intervention, closer monitoring or specialist involvement.

Assessment and diagnostic strategy

Check kidney and liver function, age-related vulnerability, pregnancy or lactation where relevant, allergies, interactions and monitoring requirements. Use prior records and trends where available, confirm test timing and sample quality, and interpret borderline results against pre-test probability rather than as binary proof of disease.

Management principles

Optimise to the lowest practical treatment burden while preserving efficacy. Communicate dose changes, monitoring ownership, missed-dose advice and toxicity warning signs. Treatment should be proportionate to severity and should preserve the ability to revise the diagnosis as new information emerges. Review contraindications, interactions, kidney and liver function, pregnancy or lactation where relevant, and the practical ability of the patient or caregiver to follow the plan.

Escalation and high-risk situations

Escalate for physiological deterioration, organ dysfunction, uncontrolled symptoms, treatment failure, or when diagnostic uncertainty carries substantial potential harm. When local expertise, imaging, monitoring or procedural capability is insufficient, specialist advice or transfer should occur before deterioration removes options.

International practice across English-speaking health systems

MDPDA is written for healthcare professionals across the United Kingdom, United States, Canada, Australia, New Zealand and Ireland. Core pathophysiology and many treatment principles are shared, but national recommendations can differ in screening eligibility, drug licensing, formularies, referral thresholds, legal duties, immunisation schedules and service access. Apply the current guideline and product information for the country in which care is delivered, and treat a cross-country difference as a reason to verify the local pathway rather than as evidence that one system is universally preferable.

Monitoring, follow-up and prevention

Follow-up should be linked to a purpose: confirmation of response, detection of complications, treatment monitoring, prevention or reassessment of the diagnosis. Define what will be measured and what result would trigger a change. Review adherence, adverse effects and barriers to care, and integrate prevention, vaccination, smoking or alcohol support, nutrition, physical activity, contraception or pregnancy planning, and psychosocial care when they materially affect outcome.

Common pitfalls and safety checks

Common avoidable errors include anchoring on an early diagnosis despite a changing clinical picture, using a test outside the population in which it is useful, failing to review medicines and organ function, and allowing ownership of abnormal results to become unclear. Reconsider the plan when response differs from expectation, a new symptom does not fit the original formulation, or treatment toxicity becomes more important than anticipated benefit. Diagnostic uncertainty should be documented and paired with explicit safety-netting rather than hidden by overconfident language.

Documentation, communication and shared decisions

Documentation should make clinical reasoning traceable. Record the working diagnosis and important alternatives, severity or risk assessment, clinically relevant negative findings, investigations that changed the plan, treatment started or withheld and the reason, and who owns pending results or follow-up. At transitions of care, reconcile medicines and clearly state warning symptoms, escalation instructions and the planned review interval. Shared decisions should describe the options discussed and the patient’s goals where more than one reasonable strategy exists.

Clinical reasoning and applicability

Clinical reasoning should remain iterative. Compare current findings with baseline, ask whether apparent severity is fully explained by the working diagnosis, and consider whether comorbidity or medication effects create a second simultaneous problem. When evidence is limited, explain the uncertainty and favour reversible, monitorable interventions while arranging the next diagnostic step. Multidisciplinary input is most valuable when it changes a decision, clarifies ownership or reduces a predictable safety risk.

Practice points for multidisciplinary care

Keep the clinical question explicit at every stage. Before discharge, transfer or treatment escalation, ask what dangerous alternative remains plausible, what objective sign would demonstrate failure of the current plan, and who will act on that sign. The aim is not maximal testing; it is a defensible sequence of decisions that improves safety and makes later review easier.

Implementation, equity and continuity

Implementation should account for health literacy, language, access to medicines and diagnostics, disability, cultural context, rural or remote location, and continuity between primary, hospital and specialist care. A technically correct plan that cannot be followed is not a safe plan. Identify practical barriers early, simplify treatment where possible, and ensure the patient or caregiver knows how to obtain help if the course changes. Where follow-up depends on another service, document the referral, urgency and responsibility for acting if the appointment or result is delayed.

Implementation, equity and continuity

Implementation should account for health literacy, language, access to medicines and diagnostics, disability, cultural context, rural or remote location, and continuity between primary, hospital and specialist care. A technically correct plan that cannot be followed is not a safe plan. Identify practical barriers early, simplify treatment where possible, and ensure the patient or caregiver knows how to obtain help if the course changes. Where follow-up depends on another service, document the referral, urgency and responsibility for acting if the appointment or result is delayed.

Implementation, equity and continuity

Implementation should account for health literacy, language, access to medicines and diagnostics, disability, cultural context, rural or remote location, and continuity between primary, hospital and specialist care. A technically correct plan that cannot be followed is not a safe plan. Identify practical barriers early, simplify treatment where possible, and ensure the patient or caregiver knows how to obtain help if the course changes. Where follow-up depends on another service, document the referral, urgency and responsibility for acting if the appointment or result is delayed.

Implementation, equity and continuity

Implementation should account for health literacy, language, access to medicines and diagnostics, disability, cultural context, rural or remote location, and continuity between primary, hospital and specialist care. A technically correct plan that cannot be followed is not a safe plan. Identify practical barriers early, simplify treatment where possible, and ensure the patient or caregiver knows how to obtain help if the course changes. Where follow-up depends on another service, document the referral, urgency and responsibility for acting if the appointment or result is delayed.

Implementation, equity and continuity

Implementation should account for health literacy, language, access to medicines and diagnostics, disability, cultural context, rural or remote location, and continuity between primary, hospital and specialist care. A technically correct plan that cannot be followed is not a safe plan. Identify practical barriers early, simplify treatment where possible, and ensure the patient or caregiver knows how to obtain help if the course changes. Where follow-up depends on another service, document the referral, urgency and responsibility for acting if the appointment or result is delayed.

Implementation, equity and continuity

Implementation should account for health literacy, language, access to medicines and diagnostics, disability, cultural context, rural or remote location, and continuity between primary, hospital and specialist care. A technically correct plan that cannot be followed is not a safe plan. Identify practical barriers early, simplify treatment where possible, and ensure the patient or caregiver knows how to obtain help if the course changes. Where follow-up depends on another service, document the referral, urgency and responsibility for acting if the appointment or result is delayed.